Gene Testing

Gene testing is a type of medical test that identifies changes in chromosomes, genes, or proteins.

news

Phico Therapeutics receives Translation Award to advance its SASPject™ PT4 aimed at Escherichia coli and Klebsiella pneumoniae towards clinical trials

9 March 2015 | By Phico Therapeutics

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject™ PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae...

news

‘Stem cell’ test could identify most aggressive breast cancers

4 March 2015 | By The Institute of Cancer Research

Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests...

news

Oncologic imaging innovation is enabling earlier detection of cancers

4 February 2015 | By Frost & Sullivan

Ongoing research aims to develop oncologic imaging technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan...

news

Motif Bio announces intention to float on AIM

3 February 2015 | By Motif Bio

Motif Bio plc is seeking to raise at least £4 million through a placing of new ordinary shares and admission to trading on AIM...

news

Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology

12 January 2015 | By Roche

Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer...

news

New targeted drugs could treat drug-resistant skin cancer

15 December 2014 | By The Institute of Cancer Research, London, and Cancer Research UK Manchester Institute

A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports...

news

ABIVAX successfully completes first-in-man study of ABX464, a highly differentiated small molecule targeting HIV

1 December 2014 | By ABIVAX

ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, announced the successful completion of its Phase 1 first-in-man study of ABX464, which has been designed to potentially deliver a number of important clinical benefits when treating patients with HIV.,,

news

New Oncology to Collaborate with National Cancer Centre Singapore on Genetic Testing

12 November 2014 | By New Oncology

New Oncology announced that it has entered into a collaboration with the National Cancer Centre Singapore (NCCS)...

news

New Oncology and Gustave Roussy announce collaboration on genetic testing

14 October 2014 | By New Oncology

New Oncology announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus, Paris...

news

Genetic testing can identify men at six-fold increased risk of prostate cancer

15 September 2014 | By The Institute of Cancer Research, London

Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified 23 new genetic variants associated with increased risk of the disease...

news

AstraZeneca and Roche announce partnership to develop companion diagnostic test for AZD9291

28 July 2014 | By AstraZeneca

AstraZeneca announced it has entered into collaboration with Roche to develop a plasma-based companion diagnostic test to support AZD9291...

news

Roche announces phase II clinical results of crenezumab in Alzheimer’s disease

17 July 2014 | By Roche

Roche presented data from two phase II studies investigating whether crenezumab can delay cognitive and functional decline in people with mild-to-moderate Alzheimer’s disease...

news

Pharma R&D Europe summits series – registration closing

16 May 2014 | By Oxford Global Conferences

Registration is now closing for Oxford Global’s Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe...

news

Janssen announces expanded collaboration with International Partnership for Microbicides for development and commercialization of dapivirine

13 May 2014 | By Johnson & Johnson

Latest innovative collaboration from the Janssen Global Public Health group and significant contribution to Johnson & Johnson’s wider efforts to improve public health worldwide...

article

Genomics In-Depth Focus 2014

7 May 2014 | By Kevin V. Morris, Bhupinder Bhullar

In this Genomics In-Depth Focus: Kevin V. Morris discusses the therapeutic potential of RNA directed epigenetic regulation of transcription, and Bhupinder Bhullar looks at drug resistance mechanisms and target selection in disease treatment strategies...